2024 KSoLA Consensus on Secondary Dyslipidemia
10.12997/jla.2024.13.3.215
- Author:
Hoyoun WON
1
;
Jae Hyun BAE
;
Hyunjung LIM
;
Minji KANG
;
Minjoo KIM
;
Sang-Hak LEE
;
Author Information
1. Cardiovascular-Arrhythmia Center, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea
- Publication Type:Review
- From:Journal of Lipid and Atherosclerosis
2024;13(3):215-231
- CountryRepublic of Korea
- Language:English
-
Abstract:
Elevated blood cholesterol and triglyceride levels induced by secondary causes are frequently observed. The identification and appropriate handling of these causes are essential for secondary dyslipidemia treatment. Major secondary causes of hypercholesterolemia and hypertriglyceridemia include an unhealthy diet, diseases and metabolic conditions affecting lipid levels, and therapeutic side effects. It is imperative to correct secondary causes prior to initiating conventional lipid-lowering therapy. Guideline-based lipid therapy can then be administered based on the subsequent lipid levels.
